176 related articles for article (PubMed ID: 37918843)
21. Multimodal assessment of acute cardiac toxicity induced by thoracic radiotherapy in cancer patients. Study protocol.
Merino T; Pinto MP; Orellana MP; Martinez G; Andía M; Munoz-Schuffenegger P; Acevedo F; Gabrielli L; Sanchez C; Pereira J
BMC Cancer; 2021 Oct; 21(1):1114. PubMed ID: 34663256
[TBL] [Abstract][Full Text] [Related]
22. Nuclear imaging in detection and monitoring of cardiotoxicity.
D'Amore C; Gargiulo P; Paolillo S; Pellegrino AM; Formisano T; Mariniello A; Della Ratta G; Iardino E; D'Amato M; La Mura L; Fabiani I; Fusco F; Perrone Filardi P
World J Radiol; 2014 Jul; 6(7):486-92. PubMed ID: 25071889
[TBL] [Abstract][Full Text] [Related]
23. Nuclear Medicine in Pediatric and Adolescent Tumors.
Kiratli PÖ; Tuncel M; Bar-Sever Z
Semin Nucl Med; 2016 Jul; 46(4):308-23. PubMed ID: 27237441
[TBL] [Abstract][Full Text] [Related]
24. Potential usefulness of diastolic parameters measured by strain imaging echocardiography in the early prediction of chemotherapy-induced cardiotoxicity.
Hernandez-Suarez DF; López-Candales A
Med Hypotheses; 2017 Apr; 101():30-32. PubMed ID: 28351486
[TBL] [Abstract][Full Text] [Related]
25. PET Tracers for Imaging Cardiac Function in Cardio-oncology.
Kelly JM; Babich JW
Curr Cardiol Rep; 2022 Mar; 24(3):247-260. PubMed ID: 35028820
[TBL] [Abstract][Full Text] [Related]
26.
El-Maouche D; Sadowski SM; Papadakis GZ; Guthrie L; Cottle-Delisle C; Merkel R; Millo C; Chen CC; Kebebew E; Collins MT
J Clin Endocrinol Metab; 2016 Oct; 101(10):3575-3581. PubMed ID: 27533306
[TBL] [Abstract][Full Text] [Related]
27. Cancer Therapeutics-Related Cardiovascular Complications. Mechanisms, Diagnosis and Treatment.
Oikonomou E; Anastasiou Μ; Siasos G; Androulakis E; Psyrri A; Toutouzas K; Tousoulis D
Curr Pharm Des; 2018; 24(37):4424-4435. PubMed ID: 30636595
[TBL] [Abstract][Full Text] [Related]
28. Scintigraphic techniques for early detection of cancer treatment-induced cardiotoxicity.
de Geus-Oei LF; Mavinkurve-Groothuis AM; Bellersen L; Gotthardt M; Oyen WJ; Kapusta L; van Laarhoven HW
J Nucl Med; 2011 Apr; 52(4):560-71. PubMed ID: 21421717
[TBL] [Abstract][Full Text] [Related]
29. The Triple-Tracer strategy against Metastatic PrOstate cancer (3TMPO) study protocol.
Pouliot F; Beauregard JM; Saad F; Trudel D; Richard PO; Turcotte É; Rousseau É; Probst S; Kassouf W; Anidjar M; Camirand Lemyre F; Bouvet GF; Neveu B; Tétu A; Guérin B
BJU Int; 2022 Sep; 130(3):314-322. PubMed ID: 34674367
[TBL] [Abstract][Full Text] [Related]
30. Multimodality Advanced Cardiovascular and Molecular Imaging for Early Detection and Monitoring of Cancer Therapy-Associated Cardiotoxicity and the Role of Artificial Intelligence and Big Data.
Kwan JM; Oikonomou EK; Henry ML; Sinusas AJ
Front Cardiovasc Med; 2022; 9():829553. PubMed ID: 35369354
[TBL] [Abstract][Full Text] [Related]
31. Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy.
Virani SA; Dent S; Brezden-Masley C; Clarke B; Davis MK; Jassal DS; Johnson C; Lemieux J; Paterson I; Sebag IA; Simmons C; Sulpher J; Thain K; Thavendiranathan P; Wentzell JR; Wurtele N; Côté MA; Fine NM; Haddad H; Hayley BD; Hopkins S; Joy AA; Rayson D; Stadnick E; Straatman L
Can J Cardiol; 2016 Jul; 32(7):831-41. PubMed ID: 27343741
[TBL] [Abstract][Full Text] [Related]
32. State-of-the-art modalities in cardio-oncology: insight from a nuclear medicine approach.
Jokar N; Amini A; Ravanbod M; Barekat M; Shooli H; Gholamrezanezhad A; Assadi M
Nucl Med Rev Cent East Eur; 2021; 24(2):82-92. PubMed ID: 34382672
[TBL] [Abstract][Full Text] [Related]
33. Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: cardiovascular magnetic resonance and nuclear cardiology.
Pepe A; Pizzino F; Gargiulo P; Perrone-Filardi P; Cadeddu C; Mele D; Monte I; Novo G; Zito C; Di Bella G
J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection():e45-e54. PubMed ID: 27755242
[TBL] [Abstract][Full Text] [Related]
34. Cardiac Complications of Cancer Therapy: Pathophysiology, Identification, Prevention, Treatment, and Future Directions.
Jain D; Russell RR; Schwartz RG; Panjrath GS; Aronow W
Curr Cardiol Rep; 2017 May; 19(5):36. PubMed ID: 28374177
[TBL] [Abstract][Full Text] [Related]
35. Cardio-oncology in Austria: cardiotoxicity and surveillance of anti-cancer therapies : Position paper of the Heart Failure Working Group of the Austrian Society of Cardiology.
Bergler-Klein J; Rainer PP; Wallner M; Zaruba MM; Dörler J; Böhmer A; Buchacher T; Frey M; Adlbrecht C; Bartsch R; Gyöngyösi M; Fürst UM
Wien Klin Wochenschr; 2022 Sep; 134(17-18):654-674. PubMed ID: 35507087
[TBL] [Abstract][Full Text] [Related]
36. Challenges and solutions in management of cardiotoxicity induced by checkpoint inhibitors.
Mladosievičová B; Országhová Z; Jablonická M; Rečková M; Chovanec M; Mego M
Klin Onkol; 2020; 33(5):350-355. PubMed ID: 33108879
[TBL] [Abstract][Full Text] [Related]
37. Discordance Between Histopathologic Grading and Dual-Tracer PET/CT Findings in Metastatic NETs and Outcome of
Adnan A; Basu S
J Nucl Med Technol; 2022 Sep; 50(3):248-255. PubMed ID: 34876476
[TBL] [Abstract][Full Text] [Related]
38. Roadmap for biomarkers of cancer therapy cardiotoxicity.
Yu AF; Ky B
Heart; 2016 Mar; 102(6):425-30. PubMed ID: 26674989
[TBL] [Abstract][Full Text] [Related]
39. Use of radioactive substances in diagnosis and treatment of neuroendocrine tumors.
Kjaer A; Knigge U
Scand J Gastroenterol; 2015 Jun; 50(6):740-7. PubMed ID: 25959100
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: cardiovascular magnetic resonance and nuclear cardiology.
Pepe A; Pizzino F; Gargiulo P; Perrone-Filardi P; Cadeddu C; Mele D; Monte I; Novo G; Zito C; Di Bella G
J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1():S45-54. PubMed ID: 27183525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
